Medical School |
M. P. Shah Medical College, Jamnagar, India |
|
1994 |
M.B.B.S. |
Residency |
University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas |
|
2000 |
M.D. |
Residency |
Chief Residency, University of Texas Health Science Center at San Antonio |
|
2001 |
M.D. |
Fellowship |
Nephrology Fellowship University of Washington, Seattle |
|
2006 |
M.D. |
Fellowship |
Basic Science Research Fellow, Northwest Kidney Center, Division of Nephrology, University of Washington, Seattle |
|
2006 |
M.D. |
Fellowship |
Transplant Nephrology Fellowship at University of Alabama at Birmingham |
|
2007 |
M.D. |
|
ECFMG Certified |
1996 |
ABIM Board Certified in Internal Medicine |
2000 |
ABIM Board Certified in Nephrology |
2006, 2017 |
ABIM Board Certified in Internal Medicine |
2010, 2020 |
|
Appointment Type |
Department |
Division |
Rank |
Center |
Ctr for Clinical & Translational Sci |
Ctr for Clinical & Translational Sci |
Professor |
Primary |
Med - Nephrology |
Med - Nephrology |
Professor |
Center |
Nephrology Research & Training Center |
Nephrology Research & Training Center |
Professor |
|
Organization Name |
Position Held |
Org Link |
American Society of Transplantation Education Committee |
Co-chair, July 2013 - June 2014 |
|
American Society of Transplantation Education Committee |
Chair, July 2014 - 2015 |
|
|
July 2016- June 2018 |
Member, Executive Council, AST Living Donor Community of Practice |
|
July 2018 - June 2020 |
Co-Chair, Executive Council, AST AST Living Donor Community of Practice |
|
July 2020- June 2021 |
Chair, Executive Council, AST AST Living Donor Community of Practice |
Member, AST Board of Directors |
July 2021 - |
https://www.myast.org/about-ast/who-we-are/board-directors |
SGIM |
Member , 2001 - 2005 |
|
ACP-ASIM |
Member, 1999 - 2004 |
|
International Society of Nephrology |
Member, 2010 - present |
|
Education Committee, American Society of Transplantation |
Member, July 2011 - 6/2013 |
|
|
Publication |
PUBMEDID |
ORIGINAL PUBLICATIONS: 1. Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Lozzo P, Lancaster JL, Cincotta A, Defronzo RA. Bromocriptine: A novel approach to the treatment of type 2 diabetes. Diabetes Care 2000 Aug; 23(8): 1154-61. 2. Iozzo P, Pratipanawatr T, Pijl H, Vogt C, Kumar V, Pipek R, Matsuda M, Mandarino LJ, Cusi KJ, DeFronzo RA. Physiologic hyperinsulinemia impairs insulin-stimulated glycogen synthetase activity and glycogen synthesis. American Journal of Physiology – Endocrinology & Metabolism 2001 May; 280(5): E712-9. 3. Diehl AK, Kumar V, Gateley A, Appleby J, O’Keefe ME. Predictors of Final Specialty Choice by Internal Medicine Residents J Gen Intern Med 2006 Oct; 21:1045-1049 4. Kumar V, Elkins S, Gaston RS, Prendergast MB, Reddy V, Cook WJ, Sanders PW. Bortezomib Successfully Reduces Monoclonal Serum Free Light Chain Levels in a Patient with Recurrent Myeloma and Cast Nephropathy in the Renal Transplant. Clinical Transplant Dec 2009. 5. Kumar V, Julian BA, Deierhoi MH, Curtis JJ. Secondary Listing for Deceased-Donor Kidney Transplantation Does not Increase Likelihood of Engraftment at a Large Transplant Center. Am J Transplantation. Brief Communication. 2009 June; 9;1671-73 6. Kumar V, Pippin J, Stein A, Jablonski P, Shankland S, Davis C. The Contribution of Podocytes to Chronic Allograft Nephropathy. Nephron Exp Nephrol 9.2009;111:e1-e10 7. Pavlakis M, Kumar V. Co-editor. Introduction to the Well-Transplant Visit – More than Vital Signs and a Creatinine Check. Clinical Journal of American Society of Nephrology. see www.CJASN.org Vol 6 pg 1773, July, 2011 8. Kumar V, Gaston RS. Advances in Kidney Transplant Immunosuppression: Emerging Biologics. Dialysis and Transplantation Jan 2011, DOI: 10.1002/dat 20525. 9. B.T. Lee, V. Kumar, T.A. Williams, R. Abdi, A. Bernhardy, C. Dyer, S. Conte, G. Genovese, M.D. Ross, D.J. Friedman. R.S. Gaston, E. Milford, M.R. Pollak, A.K. Chandraker. APOL 1 Gene Variants in African Americans Appears to Impact Long Term Kidney Allograft Survival. American Journal of Transplantation. July 2012 4.doi:10.1111/j.1600-6143.2012.04033. PMID 22487534 10. Kumar V. Medscape write up – Shaping the Future of Transplant Immunosuppression: Highlights from Boston ATC 2012. “Biologics in Solid Organ Transplantation” – Released 7/31/2012, available for CME credit until July 31 2013 11. Dawoud D, Harms J, Williams T, Kumar, V, Allon M. Predialysis Vascular Access Surgery in Patients with Failing Kidney Transplants. Am J Kidney Disease, 2013 May ajkd.2013.03.033. [Epub ahead of print] 12. Gaston RS, Kumar V, Matas AJ. Reassessing Risk in Living Kidney Donors. J Am Soc Nephrol. 2014 September 25. Pii: ASN.2014030227. [Epub ahead of print] 13. V. Kumar and J.A. Tallaj. To Transplant a Kidney With the Heart or Not – That Is the Real Question. Am J Transplant. 2014 Feb;14(2):253-4 14. Huprikar S, Danziger Isakov, Kumar V, Bloom RD, Kumar D. Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management. Am J Transplant. 2015 Feb 23. Doi: 10.1111/ajt.13187. [Epub ahead of print] 15. Lee RA, Ray M, Kasuga DT, Kumar V, Witherspoon CD, Baddley JW. Ocular bartonellosis in transplant recipients: two case reports and review of the literature. PMID: 26146758. Transpl Infect Dis. 2015 Jul 4. Doi: 10.1111/tid.12418 16. Kumar, V., Current status on the evaluation and management of the highly sensitized kidney transplant recipient. Current Opinions Nephrol Hypertens 2015 Nov;24(6):570-5 17. Ong SC, White J, Hauptfeld-Dolejsek V, Kumar V. Outcomes in Simultaneous Liver Kidney Transplants in the Setting of a Positive Crossmatch: A Single Center Experience. Clin Transpl. 2016; 32:119-125. PMID: 28564529 18. Agarwal G, Diskin CD, Williams TA, Kumar V. Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes after Intravenous Immunoglobulin Therapy. Clin Transpl. 2016; 32:111-118. PMID: 28564528 19. Locke JE, Carr JJ, Nair S, Terry JG, Reed RD, Smith GD, Segev DL, Kumar V, Lewis CE. Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates. Clin Transplant. 2017 Mar; 31(3) PMID: 28075034 20. Locke JE, Reed RD, Massie A, MacLennan PA, Sawinski D, Kumar V, Mehta S, Mannon RB, Gaston R, Lewis CE, Segev DL. Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int. 2017 Mar; 91(3):699-703. PMID:28041626 21. Smith B, Kumar V, Mompoint-Williams D, Reed RD, MacLennan PA, Stegner K, Locke JE. Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report. Transplant Proc. 2016 Nov; 48(9):3099-3105. PMID: 27932156 22. Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, Mehta S, Mannon RB, Gaston R, Julian BA, Carr JJ, Terry JG, Kilgore M, Massie AB, Segev DL, Lewis CE. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors. Ann Surg., 2017 PMID:28187045 23. Farag A, Aljaroudi W, Neill J, Doppalapudi H, Kumar V, Rizk D, Iskandrian A, Hage F. Prognostic Value of Silent Myocardial Infarction in End Stage Renal Disease., International Journal of Cardiology – Accepted, epub, September 2017 24. Ives CW, AlJaroudi WA, Kumar V, Farag A, Rizk DV, Oparil S, Iskandrian AE, Hage FG.: Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes. Eur J Nucl Med Mol Imaging. 2018 PMID: 29882159 25. Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-Year Single-Center Experience. Young CJ, MacLennan PA, Mannon EC, Reed RD, Shelton BA, Hanaway MJ, Agarwal G, Gaston RS, Julian BA, Kew CE 2nd, Kumar V, Mannon RB, Mehta S, Ong SC, Towns GC, Deierhoi MH, Locke JE. Ann Surg. 2018 May 17. Doi: 10.1097/SLA.0000000000002816. [Epub ahead of print] PMID: 29781845 26. Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, Mehta S, Mannon RB, Gaston R, Julian BA, Carr JJ, Terry JG, Kilgore M, Massie AB, Segev DL, Lewis CE.: Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors. Ann Surg. 2018 Jun; 267(6):1161-1168. PMID: 28187045 27. Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation. Reed RD, Sawinski D, Shelton BA, MacLennan PA, Hanaway M, Kumar V, Long D, Gaston RS, Kilgore ML, Julian BA, Lewis CE, Locke JE. Transplantation. 2018 Dec; 102(12):2080-2087. Doi: 10.1097/TP.0000000000002286. 28. Curtis LM, Kumar V: Sex difference in acute presentations of kidney disease. Accepted, in press, Nov, Society of Academic Emergency Medicine, Pulse, 2018 29. Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation. Locke JE, Reed RD, Kumar V, Berry B, Hendricks D, Carter A, Shelton BA, Mustian MN, MacLennan PA, Qu H, Hannon L, Yates C, Hanaway MJ. Transplantation. 2019 Apr 1. Doi: 10.1097/TP.0000000000002732. [Epub ahead of print] PMID: 30946213 30. Obesity and long-term mortality risk among living kidney donors. Locke JE, Reed RD, Massie AB, MacLennan PA, Sawinski D, Kumar V, Snyder JJ, Carter AJ, Shelton BA, Mustian MN, Lewis CE, Segev DL. Surgery. 2019 May 6. Pii: S0039-6060(19)30167-9. Doi: 10.1016/j.surg.2019.03.016. [Epub ahead of print] PMID: 31072668 31. Patient Perspectives on Weight Management for Living Kidney Donation. Mustian MN, Hanaway M, Kumar V, Reed RD, Shelton BA, Grant R, Carter A, Locke JE. J Surg Res. 2019 Jul 3; 244:50-56. Doi: 10.1016/j.jss.2019.06.026. [Epub ahead of print]PMID:31279263 32. Mitigating Racial and Gender Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-Center Kidney Chain. Annals of Surgery, Accepted April 2019, in press, Kumar V, Locke JE 33. Pregnancy in a Kidney Transplant Patient. Ong SC, Kumar V. Clin J Am Soc Nephrol. 2019 Aug 26. pii: CJN.03910319. doi: 10.2215/CJN.03910319. [Epub ahead of print]. PMID: 31451514 34. Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome. Mustian MN, Kumar V, Hanaway M, MacLennan PA, Shelton BA, Reed RD, Correya T, Grant R, Carter A, Baker G, Patterson J, Peoples M, Holden S, Orandi BJ, Locke JE. Surgery. 2019 Aug 20. pii: S0039-6060(19)30456-8. doi: 10.1016/j.surg.2019.07.008. [Epub ahead of print] PMID: 31444005 35. Clinical Pig Kidney Xenotransplantation: How Close Are We? Cooper DKC, Hara H, Iwase H, Yamamoto T, Jagdale A, Kumar V, Mannon RB, Hanaway MJ, Anderson DJ, Eckhoff DE. J Am Soc Nephrol. 2020 Jan;31(1):12-21. doi: 10.1681/ASN.2019070651. Epub 2019 Dec 2. 36. Evaluation and Care of International Living Kidney Donor Candidates: Strategies for Addressing Common Considerations & Challenges, Ellen Shukhman, RN,1* Julia Hunt, MSW,2* Dianne LaPointe-Rudow, DNP,2 Didier Mandelbrot, MD,3 Vineeta Kumar, MD,4 Heidi Schaefer, MD,5 Fawaz Al Ammary, MD, PhD,6 Macey L. Henderson, JD,6 PhD, Angie Nishio-Lucar, MD,7 Matthew Cooper, MD,8 Rebecca Hays, MSW, APSW,3 Krista L. Lentine, MD, PhD9. Clinical Transplantation 37. Attitudes to Clinical Pig Kidney Xenotransplantation among Medical Providers and Patients. Luz A. Padilla, Daniel Hurst, Raymond Lopez, Vineeta Kumar, David K.C. Cooper and Wayne Paris Kidney360 July 2020, 1 (7) 657-662; https://doi.org/10.34067/KID.0002082020 38. Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation Article in The Journal of Heart and Lung Transplantation 39(4):S366-S367 10.1016/j.healun.2020.01.451 39. Use of Patient Navigators to Reduce Barriers in Living Donation and Living Donor Transplantation, AG Nishio-Lucar, J Locke, V Kumar. Current Transplantation Reports (2020) 7:72–80. https://doi.org/10.1007/s40472-020-00280-4 40. Reed RD, Kale AC, Mustian MN, Hendricks DH, Baldwin KN, Kumar V, Dionne-Odom JN, Saag K, Hites L, Ivankova NV, Locke JL. The Living Donor Navigator Program Provides Support Tools for Caregivers. Progress in Transplantation, September 15, 2020. 41. Care of International Living Kidney Donor Candidates in the United States: A Survey of Contemporary Experience, Practice and Challenges. Lentine KL, Motter JD, Henderson ML, Hays RE, Shukhman E, Hunt J, Al Ammary F, Kumar V, LaPointe Rudow D, Van Pilsum Rasmussen SE, Nishio-Lucar AG, Schaefer HM, Cooper M, Mandelbrot DA. Clin Transplant. 2020 Aug 17:e14064. doi: 10.1111/ctr.14064. Online ahead of print.Clin Transplant. 2020. PMID: 32808320 42. Pig Kidney Xenotransplantation: Progress Towards Clinical Trials. Cooper DKC, Hara H, Iwase H, Yamamoto T, Wang ZY, Jagdale A, Bikhet MH, Nguyen HQ, Foote JB, Paris WD, Ayares D, Kumar V, Anderson DJ, Locke JE, Eckhoff DE. Clin Transplant. 2020 Nov 1:e14139. doi: 10.1111/ctr.14139. PMID: 33131148 43. Impact of early subclinical borderline changes and microvascular injury on kidney transplant outcomes" Transplantation Direct Impact of Subclinical Borderline Inflammation on Kidney Transplant OutcomesJanuary 2021, Transplantation Direct 7(2):e663, DOI: 10.1097/TXD.0000000000001119 44. Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 EraKidney Int Rep . 2020 Nov;5(11):1894-1905. doi: 10.1016/j.ekir.2020.08.017. Epub 2020 Aug 25. Krista L Lentine, Luke S Vest, Mark A Schnitzler , Roslyn B Mannon , Vineeta Kumar , Mona D Doshi , Matthew Cooper, Didier A Mandelbrot, Meera N Harhay, Michelle A Josephson, Yasar Caliskan, Asif Sharfuddin, Bertram L Kasiske, David A Axelrod 45. AJKD - KDOQI US Commentary on the KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation March 2021 46. Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population: A cohort study Babak J Orandi 1, Cora E Lewis, Paul A MacLennan, Haiyan Qu, Shikha Mehta, Vineeta Kumar, Saulat S Sheikh, Robert M Cannon, Douglas J Anderson, Michael J Hanaway, Rhiannon D Reed, A Cozette Killian, Joshua W Purvis, Norah A Terrault, Jayme E Locke. PMID: 34338423 DOI: 10.1002/oby.23195 August 2021 https://doi.org/10.1002/oby.23195 47. Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney Transplant A Cozette Killian , Brittany Shelton, Paul MacLennan, M Chandler McLeod, Alexis Carter, Rhiannon Reed, Haiyan Qu, Babak Orandi, Vineeta Kumar, Deirdre Sawinski , Jayme E Locke. PMID: 34524392 DOI: 10.1001/jamasurg.2021.4410 JAMA Surg 2021 Sep 15. doi: 10.1001/jamasurg.2021.4410. 48. Operational challenges in the COVID era: Asymptomatic infections and vaccination timing. Axelrod DA, Ince D, Harhay MN, Mannon RB, Alhamad T, Cooper M, Josephson MA, Caliskan Y, Sharfuddin A, Kumar V, Guenette A, Schnitzler MA, Ainapurapu S, Lentine KL. Clin Transplant. 2021 Jul 23:10.1111/ctr.14437. doi: 10.1111/ctr.14437. Online ahead of print. PMID: 34297878 49. A National Survey of Practice Patterns for Accepting Living Kidney Donors With Prior COVID-19. Jan MY, Jawed AT, Barros N, Adebiyi O, Diez A, Fridell JA, Goggins WC, Yaqub MS, Anderson MD, Mujtaba MA, Taber TE, Mishler DP, Kumar V, Lentine KL, Sharfuddin AA. Kidney Int Rep. 2021 Aug;6(8):2066-2074. doi: 10.1016/j.ekir.2021.05.003. Epub 2021 May 15. PMID: 34027242 Free PMC article. 50. New Perspectives on Desensitization in the Current Era - An Overview. Kumar V, Locke JE. Front Immunol. 2021 Jul 30;12:696467. doi: 10.3389/fimmu.2021.696467. eCollection 2021. PMID: 34394089 Free PMC article. Review 51. APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra). Kumar V, Locke JE. Kidney Int. 2021 Jul;100(1):30-32. doi: 10.1016/j.kint.2021.02.041. PMID: 34154720 52. Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States.Jagdale A, Kumar V, Anderson DJ, Locke JE, Hanaway MJ, Eckhoff DE, Iwase H, Cooper DKC. Transplantation. 2021 Sep 1;105(9):1904-1908. doi: 10.1097/TP.0000000000003632. PMID: 33481554 53. Self-advocacy is associated with lower likelihood of living donor kidney transplantation A Cozette Killian, Rhiannon D Reed, Alexis Carter, M Chandler McLeod, Brittany A Shelton, Vineeta Kumar, Haiyan Qu , Paul A MacLennan, Babak J Orandi, Robert M Cannon, Douglas Anderson, Michael J Hanaway, Jayme E Locke PMID: 33413873 PMCID: PMC8217080 (available on 2022-07-01) DOI: 10.1016/j.amjsurg.2020.12.035 54. Effect of left ventricular mechanical dyssynchrony assessed pre-renal transplantation on cardiovascular death post transplantation. William S Morgan, Christopher W Ives, Ayman A Farag, Vineeta Kumar, Pradeep Bhambhvani, Ami E Iskandrian, Fadi G Hage. J Nucl Cardiol . 2021 Oct 22. doi: 10.1007/s12350-021-02818-0. 55. Impact of Social Vulnerability on Access to Educational Programming Designed to Enhance Living Donation. Carter, A. J., Reed, R. D., Kale, A. C., Qu, H., Kumar, V., Hanaway, M. J., Cannon, R. M., & Locke, J. E. (2021). PMID: 34713750 2021.Progress in Transplantation. Online ahead of print on 10/29/2021, PMID: 34713750, https://doi.org/10.1177/15269248211046014
BOOK CHAPTERS: PUBLISHED BOOK CHAPTERS: 1. Kumar V, Gaston RS. Chapter Contribution: Immunosuppression: Past, present, and future. Organ Transplantation, a Clinical Guide. 2011. 0780521197533 Hardback 2. Evaluation of Metabolic and Cardiovascular Risks in Living Donor Candidates. Living Kidney Donation pp 141-159. Metabolic and Cardiovascular Risks for Living Kidney Donation: Best Practices in Evaluation, Care and Follow-up. DOI: 10.1007/978-3-030-53618-3_6. March 2021, Margaux N. Mustian, Vineeta Kumar, Jayme Locke |
|
|
|